Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 18,616 | 18,090 | 19,853 | 19,581 | 22,227 |
| Operating Income | -18,616 | -18,090 | -19,853 | -19,581 | -22,227 |
| Other Income | 277 | 244 | 131 | 160 | 166 |
| Pre-tax Income | -18,339 | -17,846 | -19,722 | -19,421 | -22,061 |
| Net Income Continuous | -18,339 | -17,846 | -19,722 | -19,421 | -22,061 |
| Net Income | $-18,339 | $-17,846 | $-19,722 | $-19,421 | $-22,061 |
| EPS Basic Total Ops | -0.74 | -0.73 | -0.99 | -0.97 | -1.11 |
| EPS Basic Continuous Ops | -0.74 | -0.73 | -0.99 | -0.97 | -1.11 |
| EPS Diluted Total Ops | -0.74 | -0.73 | -0.99 | -0.97 | -1.11 |
| EPS Diluted Continuous Ops | -0.74 | -0.73 | -0.99 | -0.97 | -1.11 |
| EBITDA(a) | $-18,677 | $-18,116 | $-19,811 | $-19,562 | $-22,173 |